OKYO Pharma (NASDAQ:OKYO) Stock Price Down 1% – Time to Sell?

OKYO Pharma Limited (NASDAQ:OKYO) shares were down 1% during mid-day trading on Wednesday . The stock traded as low as $1.03 and last traded at $1.04. Approximately 12,750 shares were traded during trading, a decline of 90% from the average daily volume of 123,111 shares. The stock had previously closed at $1.05.

Analysts Set New Price Targets

Separately, HC Wainwright restated a “buy” rating and set a $7.00 price target on shares of OKYO Pharma in a research note on Thursday, October 24th.

OKYO Pharma Trading Down 1.8 %

The stock has a fifty day moving average of $1.07 and a 200 day moving average of $1.18.

About OKYO Pharma

OKYO Pharma Limited, a clinical-stage biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. Its lead preclinical product candidate is OK-101, which is in Phase II clinical trials for the treatment of dry eye disease.